GE Healthcare, the healthcare business of GE (NYSE:GE), announced on Monday an agreement with ulrich GmbH & Co KG (ulrich medical) to offer a GE Healthcare branded contrast media injector in the United States.
Based in Germany, ulrich medical develops, produces and distributes spinal systems and contrast medium injectors.
GE Healthcare's CT motion multi-dose syringeless injector, which delivers iodinated contrast media for Computed Tomography (CT) imaging procedures, is designed to reduce procedure setup time and increase patient throughput by eliminating time consuming preparation steps, while helping to optimise patient dosing and reduce wasted contrast media.
New research shows savings of up to three minutes and 30mL of contrast media per patient procedure with the CT motion versus a typical syringe-based injector, GE said.
Moderna reports positive interim results from next-generation COVID-19 vaccine trial
Scancell initiates SCOPE trial's iSCIB1+ cohort
Valneva launches Phase 1 trial for next-generation Zika vaccine
argenx obtains VYVGART approval for primary immune thrombocytopenia in Japan
Bio-Thera Solutions' BAT8006 phase II Study receives US FDA IND approval
Biocytogen and ABL Bio collaborate on development of new bispecific antibody-drug conjugates
BenevolentAI reports positive Phase Ia safety and pharmacokinetic data for BEN-8744
AstraZeneca announces US approval for Ultomiris for NMOSD treatment